RT Journal Article
SR Electronic
T1 Mortality of patients with COPD participating in chronic disease management programmes: a happy end?
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 865
OP 866
DO 10.1136/thoraxjnl-2013-204983
VO 69
IS 9
A1 I Peytremann-Bridevaux
A1 P Taffe
A1 B Burnand
A1 P O Bridevaux
A1 M A Puhan
YR 2014
UL http://thorax.bmj.com/content/69/9/865.abstract
AB Background Concerns about increased mortality could question the role of COPD chronic disease management (CDM) programmes. We aimed at extending a recent Cochrane review to assess the effects of CDM on mortality in patients with COPD. Methods Mortality data were available for 25 out of 29 trials identified in a COPD integrated care systematic review. Meta-analysis using random-effects models was performed, followed by subgroup analyses according to study length (3–12 months vs >12 months), main intervention component (exercise, self-management, structured follow-up) and use of an action plan. Results The meta-analysis showed no impact of CDM on mortality (pooled OR: 1.00, 95% CI 0.79 to 1.28). Conclusions These results do not suggest that CDM programmes expose patients with COPD to excessive mortality risk.